Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02556398 · ClinicalTrials.gov registry record · NA

Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control

A NA study of Type 1 Diabetes, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT02556398 is a NA study of Type 1 Diabetes that has completed, run by Joslin Diabetes Center. The registered enrollment target is 35 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02556398, a NA study of Type 1 Diabetes, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The project involve evaluation of a web-based nutrition education program and pilot-testing of a new smartphone app for real-time data logging to identify factors causing glycemic variability.

Conditions Studied

Interventions

  • BEHAVIORAL Sugar Sleuth

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2015-09
Est. Completion 2021-01-22
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT02556398

The ClinicalTrials.gov registry entry for NCT02556398 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Sugar Sleuth is the first listed.

NCT02556398 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02556398 about?

NCT02556398 is a clinical study titled "Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control". The project involve evaluation of a web-based nutrition education program and pilot-testing of a new smartphone app for real-time data logging to identify factors causing glycemic variability.

What is the current status of trial NCT02556398?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2015-09. Estimated completion is 2021-01-22.

What conditions does trial NCT02556398 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT02556398?

The interventions under investigation include: Sugar Sleuth (BEHAVIORAL).

Who is sponsoring clinical trial NCT02556398?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02556398 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.